BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22001609)

  • 21. Synthesis and evaluation of human serum albumin-modified exendin-4 conjugate via heterobifunctional polyethylene glycol linkage with protracted hypoglycemic efficacy.
    Kim I; Kim TH; Ma K; Lee ES; Kim D; Oh KT; Lee DH; Lee KC; Youn YS
    Bioconjug Chem; 2010 Aug; 21(8):1513-9. PubMed ID: 20715855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical studies on Helicobacter pylori arginase: insight into the difference in activity compared to other arginases.
    Srivastava A; Sau AK
    IUBMB Life; 2010 Dec; 62(12):906-15. PubMed ID: 21190293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression, purification and characterization of arginase from Helicobacter pylori in its apo form.
    Zhang J; Zhang X; Wu C; Lu D; Guo G; Mao X; Zhang Y; Wang DC; Li D; Zou Q
    PLoS One; 2011; 6(10):e26205. PubMed ID: 22028830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and immobilization of L-arginase from thermotolerant Penicillium chrysogenum KJ185377.1; with unique kinetic properties as thermostable anticancer enzyme.
    El-Sayed AS; Shindia AA; Diab AA; Rady AM
    Arch Pharm Res; 2014 Oct; ():. PubMed ID: 25322968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous recovery of dual pathways for ammonia metabolism do not improve further detoxification of ammonia in HepG2 cells.
    Zhang FY; Tang NH; Wang XQ; Li XJ; Chen YL
    Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):525-32. PubMed ID: 24103284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PEGylation and pharmacological characterization of a potential anti-tumor drug, an engineered arginine deiminase originated from Pseudomonas plecoglossicida.
    Zhang L; Liu M; Jamil S; Han R; Xu G; Ni Y
    Cancer Lett; 2015 Feb; 357(1):346-354. PubMed ID: 25462857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of a non-immunogenic arginase by the covalent attachment of polyethylene glycol.
    Savoca KV; Abuchowski A; van Es T; Davis FF; Palczuk NC
    Biochim Biophys Acta; 1979 May; 578(1):47-53. PubMed ID: 454671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies.
    Izzo F; Marra P; Beneduce G; Castello G; Vallone P; De Rosa V; Cremona F; Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA; Ng C; Curley SA
    J Clin Oncol; 2004 May; 22(10):1815-22. PubMed ID: 15143074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent.
    Nasreddine G; El-Sibai M; Abi-Habib RJ
    Invest New Drugs; 2020 Feb; 38(1):10-19. PubMed ID: 30887252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of poly(ethylene glycol) by cell-based anti-poly(ethylene glycol) ELISA.
    Chuang KH; Tzou SC; Cheng TC; Kao CH; Tseng WL; Shiea J; Liao KW; Wang YM; Chang YC; Huang BJ; Wu CJ; Chu PY; Roffler SR; Cheng TL
    Anal Chem; 2010 Mar; 82(6):2355-62. PubMed ID: 20178318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimized siRNA-PEG conjugates for extended blood circulation and reduced urine excretion in mice.
    Iversen F; Yang C; Dagnæs-Hansen F; Schaffert DH; Kjems J; Gao S
    Theranostics; 2013; 3(3):201-9. PubMed ID: 23471415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature.
    Eder M; Krivoshein AV; Backer M; Backer JM; Haberkorn U; Eisenhut M
    Nucl Med Biol; 2010 May; 37(4):405-12. PubMed ID: 20447550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.
    Tomlinson BK; Thomson JA; Bomalaski JS; Diaz M; Akande T; Mahaffey N; Li T; Dutia MP; Kelly K; Gong IY; Semrad T; Gandara DR; Pan CX; Lara PN
    Clin Cancer Res; 2015 Jun; 21(11):2480-6. PubMed ID: 25739672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of site-specific ScFv PEGylation for tumor-targeting pharmaceuticals.
    Natarajan A; Xiong CY; Albrecht H; DeNardo GL; DeNardo SJ
    Bioconjug Chem; 2005; 16(1):113-21. PubMed ID: 15656582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A repeated injection of polyethyleneglycol-conjugated recombinant human butyrylcholinesterase elicits immune response in mice.
    Chilukuri N; Sun W; Parikh K; Naik RS; Tang L; Doctor BP; Saxena A
    Toxicol Appl Pharmacol; 2008 Sep; 231(3):423-9. PubMed ID: 18586293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma.
    Cheng PN; Leung YC; Lo WH; Tsui SM; Lam KC
    Cancer Lett; 2005 Jun; 224(1):67-80. PubMed ID: 15911102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c mice.
    Reguera RM; Balaña-Fouce R; Showalter M; Hickerson S; Beverley SM
    Mol Biochem Parasitol; 2009 May; 165(1):48-56. PubMed ID: 19393161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies.
    Ascierto PA; Scala S; Castello G; Daponte A; Simeone E; Ottaiano A; Beneduce G; De Rosa V; Izzo F; Melucci MT; Ensor CM; Prestayko AW; Holtsberg FW; Bomalaski JS; Clark MA; Savaraj N; Feun LG; Logan TF
    J Clin Oncol; 2005 Oct; 23(30):7660-8. PubMed ID: 16234528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Readily adaptable release kinetics of prodrugs using protease-dependent reversible PEGylation.
    Böttger R; Knappe D; Hoffmann R
    J Control Release; 2016 May; 230():88-94. PubMed ID: 27067364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers.
    Lu J; Huang Y; Zhao W; Marquez RT; Meng X; Li J; Gao X; Venkataramanan R; Wang Z; Li S
    Biomaterials; 2013 Feb; 34(5):1591-600. PubMed ID: 23182923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.